Sale of Securities

Rapport Therapeutics, Inc. Filed 2025-09-17 Acc 0001950047-25-007277

Documents 1

2025-09-18 SCHEDULE 13D/A Beneficial Ownership Report
2025-09-17 144 Sale of Securities
2025-09-17 144 Sale of Securities
2025-09-17 4 Chief Scientific Officer sold 8,500 shares at an average $24.19 ($205,649)
2025-09-15 4 Director bought 20,400 shares at $24.48 ($499,374)
2025-09-15 4 Director bought 41,666 shares at an average $24.65 ($1,027,111)
2025-09-08 144 Sale of Securities

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…